A Randomized Phase III Study of Patients With Advanced Gastric Adenocarcinoma Without Progression After Six Cycles of XELOX (Capecitabine Plus Oxaliplatin) Followed by Capecitabine Maintenance or Clinical Observationgastric cancerIF3.82023-01-011OAAI
Efficacy of capecitabine and oxaliplatin versus S-1 as adjuvant chemotherapy in gastric cancer after D2 lymph node dissection according to lymph node ratio and N stageBMC CANCERIF3.42019-12-1812OAAI
Discordancy and changes in the pattern of programmed death ligand 1 expression before and after platinum-based chemotherapy in metastatic gastric cancerGASTRIC CANCERIF5.12018-06-0218OAAI
Different clinical outcomes of systemic chemotherapy in non-small cell lung cancer without EGFR and K-ras mutation according to smoking status.MOLECULAR CANCER THERAPEUTICSIF5.52013-11-010PRE
The Clinopatholigic Characterization of Gastrointestinal Neuroendocrine Tumor in Korea: A Single-Center Retrospective StudyAMERICAN JOURNAL OF GASTROENTEROLOGYIF7.62012-10-010PRE
Treatment outcomes of systemic chemotherapy for peritoneal carcinomatosis arising from gastric cancer with no measurable disease: retrospective analysis from a single centerGASTRIC CANCERIF5.12012-08-1730OA
Prognostic significance of CD44s expression in resected non-small cell lung cancerBMC CANCERIF3.42011-08-0743OAAI
Pancreatic Endocrine Tumors: A Report on a Patient Treated with SorafenibJOURNAL OF KOREAN MEDICAL SCIENCEIF2.32011-01-012OAAI
Change in Cancer Pain Management in Korea Between 2001 and 2006: Results of Two Nationwide SurveysJOURNAL OF PAIN AND SYMPTOM MANAGEMENTIF3.52011-01-0128OAAI
Effect of sorafenib on experimental choroidal neovascularization in the ratCLINICAL AND EXPERIMENTAL OPHTHALMOLOGYIF5.62010-05-2412PREAI